Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probucol to Increase CSF ApoE in Persons at Risk of Alzheimer's
NCT02707458Phase 2Completed
- Sponsor
- Douglas Mental Health University Institute
- Start
- Apr 2016
- Primary completion
- Mar 2017
- Countries
- 1
01
Overview
A Phase 2 trial of probucol in Alzheimer's disease (AD), sponsored by Douglas Mental Health University Institute. Started Apr 2016; status: completed.
02
Drugs
probucol
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02707458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02707458.